Seeing Is Believing
Currently out of the existing stock ratings of Daniil Gataulin, 38 are a BUY (80.85%), 9 are a HOLD (19.15%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 20.04% that have a potential upside of 33.45% achieved within 152 days.
Daniil Gataulin’s has documented 87 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ADVM, Adverum Biotechnologies at 15-May-2025.
Analyst best performing recommendations are on OTLK (OUTLOOK THERAPEUTICS INC).
The best stock recommendation documented was for OTLK (OUTLOOK THERAPEUTICS INC) at 8/15/2023. The price target of $10 was fulfilled within 15 days with a profit of $21 (67.74%) receiving and performance score of 45.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
$1.79 (81.00%)
$5
9 days ago
(15-May-2025)
1/5 (20%)
$1.95 (95.12%)
81
Buy
$33
$30.79 (1393.21%)
$33
9 days ago
(15-May-2025)
3/7 (42.86%)
$30.95 (1509.76%)
884
Buy
$30
$27.79 (1257.47%)
$30
9 days ago
(15-May-2025)
0/6 (0%)
$27.95 (1363.41%)
Buy
$16
$13.79 (623.98%)
$20
6 months 2 days ago
(22-Nov-2024)
1/3 (33.33%)
$9.96 (164.90%)
292
Buy
$6
$4.05 (207.69%)
$4
1 years 8 months 19 days ago
(05-Sep-2023)
4/7 (57.14%)
$4.22 (237.08%)
196
Which stock is Daniil Gataulin is most bullish on?
Which stock is Daniil Gataulin is most reserved on?
What Year was the first public recommendation made by Daniil Gataulin?